Abstract
Human autocrine motility factor (hAMF), a tumor-secreted cytokine which stimulates cell migration in vitro and metastasis in vivo, has been crystallized by the hanging-drop vapour diffusion method. The crystals belong to an orthorhombic space group P212121 with the cell dimensions of a = 80.79 A, b = 107.1 A, and c = 270.9 A. There are two dimers per asymmetric unit. The crystals diffract to at least 2.0 A resolution and are suitable for X-ray structure analysis at high resolution.
Keywords: Crystallization, Motility Factor, cytokine
Protein & Peptide Letters
Title: Crystallization and Preliminary X-Ray Crystallographic Studies of Human Autocrine Motility Factor
Volume: 8 Issue: 4
Author(s): Hiroshi Uemura, Nobutada Tanaka, Tatsuyshi Funasaka, Arayo Haga, Hisamitsu Nagase, Avraham Raz and Kazuo T. Nakamura
Affiliation:
Keywords: Crystallization, Motility Factor, cytokine
Abstract: Human autocrine motility factor (hAMF), a tumor-secreted cytokine which stimulates cell migration in vitro and metastasis in vivo, has been crystallized by the hanging-drop vapour diffusion method. The crystals belong to an orthorhombic space group P212121 with the cell dimensions of a = 80.79 A, b = 107.1 A, and c = 270.9 A. There are two dimers per asymmetric unit. The crystals diffract to at least 2.0 A resolution and are suitable for X-ray structure analysis at high resolution.
Export Options
About this article
Cite this article as:
Uemura Hiroshi, Tanaka Nobutada, Funasaka Tatsuyshi, Haga Arayo, Nagase Hisamitsu, Raz Avraham and Nakamura T. Kazuo, Crystallization and Preliminary X-Ray Crystallographic Studies of Human Autocrine Motility Factor, Protein & Peptide Letters 2001; 8 (4) . https://dx.doi.org/10.2174/0929866013409364
DOI https://dx.doi.org/10.2174/0929866013409364 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis
Current Pharmaceutical Design The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Current Drug Targets Editorial from Guest Editors [Hot Topic: Viral Bronchiolitis: The Year in Review (Guest Editors: Louis Bont and Jan Kimpen)]
Current Respiratory Medicine Reviews Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: New Therapeutic Options in Central Nervous System Involvement of Rheumatologic Diseases (Executive Editor: Ali Gur)]
Current Pharmaceutical Design Editorial: Exciting Progresses in Stem Cell and Neural Stem Cell Research
Current Molecular Medicine Drug-Induced Pulmonary Hypertension in Newborns: A Review.
Current Vascular Pharmacology Transcriptional Regulation of Antimicrobial Host Defense Peptides
Current Protein & Peptide Science On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
Current Drug Metabolism Diclofenac 1,3,4-Oxadiazole Derivatives; Biology-Oriented Drug Synthesis (BIODS) in Search of Better Non-Steroidal, Non-Acid Antiinflammatory Agents
Medicinal Chemistry Inflammation in Neurodegenerative Disorders: Friend or Foe?
Current Aging Science Synthetic Inhibitors of Group IVA and Group VIA Phospholipase A2
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Enzyme Mediated Baeyer-Villiger Oxidations
Current Organic Chemistry Chikungunya Infection and Immunity: An Overview
Current Immunology Reviews (Discontinued) Antibody Targeting of TGF-β in Cancer Patients
Current Pharmaceutical Biotechnology Cancer Stem Cells Switch on Tumor Neovascularization
Current Molecular Medicine Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets
Current Gene Therapy Pharmacogenetics and Inflammatory Bowel Disease
Current Pharmacogenomics and Personalized Medicine Targeting Fibrosis in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery